BIOMARIN PHARMACEUTICAL INC

CUSIP: 09061GAH4 Class: Convertible Debt

OPPENHEIMER ASSET MANAGEMENT INC.'s Holding History (CIK: 0001269119)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 151,000 Value ($000) $148 Avg Close Range
Q4 2023
Shares 299,000 Value ($000) $295 Avg Close Range
Q3 2023
Shares 266,000 Value ($000) $258 Avg Close Range
Q2 2023
Shares 206,000 Value ($000) $202 Avg Close Range
Q1 2023
Shares 168,000 Value ($000) $172 Avg Close Range
Q4 2022
Shares 169,000 Value ($000) $179 Avg Close Range
Q3 2022
Shares 165,000 Value ($000) $163 Avg Close Range
Q2 2022
Shares 172,000 Value ($000) $170 Avg Close Range
Q1 2022
Shares 185,000 Value ($000) $185 Avg Close Range
Q4 2021
Shares 188,000 Value ($000) $197 Avg Close Range
Q3 2021
Shares 202,000 Value ($000) $207 Avg Close Range
Q2 2021
Shares 209,000 Value ($000) $217 Avg Close Range
Q1 2021
Shares 165,000 Value ($000) $167 Avg Close Range
Q4 2020
Shares 162,000 Value ($000) $174 Avg Close Range
Q3 2020
Shares 88,000 Value ($000) $92 Avg Close Range
Q2 2020
Shares 87,000 Value ($000) $106 Avg Close Range
Q1 2020
Shares 87,000 Value ($000) $91 Avg Close Range
Q4 2019
Shares 86,000 Value ($000) $91 Avg Close Range
Q3 2019
Shares 93,000 Value ($000) $91 Avg Close Range
Q2 2019
Shares 94,000 Value ($000) $98 Avg Close Range
Q1 2019
Shares 88,000 Value ($000) $90 Avg Close Range
Q4 2018
Shares 73,000 Value ($000) $73 Avg Close Range
Q3 2018
Shares 93,000 Value ($000) $99 Avg Close Range